Document is current
Any future updates will be listed below
-
Authors
Lahiguera, Álvaro
Hyroššová, Petra
Figueras, Agnès
Garzón, Diana
Moreno, Roger
Soto‐Cerrato, Vanessa
McNeish, Iain
Serra, Violeta https://orcid.org/0000-0001-6620-1065
Lazaro, Conxi
Barretina, Pilar
Brunet, Joan
Menéndez, Javier
Matias‐Guiu, Xavier
Vidal, August
Villanueva, Alberto
Taylor‐Harding, Barbie
Tanaka, Hisashi
Orsulic, Sandra
Junza, Alexandra
Yanes, Oscar
Muñoz‐Pinedo, Cristina
Palomero, Luís
Pujana, Miquel Àngel
Perales, José Carlos
Viñals, Francesc https://orcid.org/0000-0002-9918-6751
-
Funding
Funding for this research was provided by:
Ministerio de Economía, Industria y Competitividad, Gobierno de España (SAF2017-85869-R)
Ministerio de Economía, Industria y Competitividad, Gobierno de España (BFU2015-66030)
MEC | Instituto de Salud Carlos III (FIS PI15/00854)
MEC | Instituto de Salud Carlos III (FIS PI16/01898)
Generalitat de Catalunya (2017SGR449)
- License Information
-
More Information
Article History
Received: 26 July 2019
Revised: 5 April 2020
Accepted: 9 April 2020
First Online: 13 May 2020
Conflict of interest
: This study was supported by unrestricted grant from Roche to finance the ProCure Programme, which was paid to the Catalan Institute of Oncology (2015).
